SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Visible Genetics Inc.(VGIN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext  
To: keokalani'nui who wrote (336)9/13/2002 12:33:14 AM
From: mopgcw   of 337
 
K2 Arbitrage Fund Reports 7.73% Stake In Visible Genetics

DOW JONES NEWSWIRES

WASHINGTON -- K2 Arbitrage Fund L.P. reported holding a 7.73% stake in Visible Genetics Inc. (VGIN), according to a Schedule 13G filed Thursday with the Securities and Exchange Commission.

On Sept. 4, K2 Arbitrage Fund beneficially owned 1,484,154 Visible Genetics common shares.

A Schedule 13G denotes a passive investment stake in a company. Filers aren't required to provide a reason for any changes in stake and aren't required to detail any transactions.

Visible Genetics makes and markets automated DNA sequencing systems and diagnostic kits to analyze genes linked to diseases.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext